Search

everythinglearnresearchcommunity

for

Search:↓

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

All five human steroid 5α-reductase enzymes are found in the endoplasmic reticulum.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

Stinging nettle has compounds that help with joint pain, arthritis, and prostate issues.

Saw palmetto extract reduced hair loss and improved hair growth in people with hair thinning.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

White hair grows thicker and faster than black hair due to higher activity of growth-related genes and proteins.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Post-finasteride syndrome is rare but serious and should be taken seriously.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Steroids, particularly estrogens and 5α-reductase inhibitors, affect blood vessel-related hair growth processes in hair follicle cells.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Testosterone increases seizure risk through its conversion to specific neurosteroids.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.